Nir Naor
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Nir Naor
Nir Naor was last confirmed as Board Member at Brainstorm Cell Therapeutics Inc. (BCLI) in a filing dated August 16, 2024. Brainstorm Cell Therapeutics Inc. reported in an 8-K filed September 16, 2024 that Nir Naor was appointed Director, effective September 16, 2024. Brainstorm Cell Therapeutics Inc. reported in an 8-K filed June 20, 2023 that Nir Naor was appointed member of the Board, effective June 20, 2023.
“Stockholders elected the seven (7) nominees (listed below) for election to the Company's Board to hold office until the next annual meeting of stockholders and until their successors are duly elected and qualified or until their earlier resignation or removal, based upon the following votes:”
“On June 19, 2023, the Board elected Nir Naor to serve as a member of the Board, effective June 20, 2023, filling the vacancy created by Mr. Taub's resignation.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2024-08-16
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.